Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,032,007
-$17,021,699 QoQ
Shares Held
2,016,379
-47.3% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#26
of 247 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Derivatives in TNGX
reported options exposure · as of Jun 30, 2026CallValue
$3,126,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. TNGX ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
This page
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in TNGX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,032,007 | 2,016,379 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $3,126,000 | 100,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $80,053,706 | 3,826,659 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $46,768,218 | 5,278,580 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $29,166,538 | 3,472,207 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,627,010 | 3,247,463 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,410,812 | 3,219,571 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,132,715 | 3,279,196 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,691,409 | 2,687,196 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,376,737 | 277,009 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $9,507,685 | 844,377 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $240,899 | 31,781 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||